Return On Equity in % of LEAP THERAPEUTICS, INC. from Q3 2017 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Leap Therapeutics, Inc. quarterly/annual Return On Equity history and change rate from Q3 2017 to Q3 2025.
  • Leap Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2025 was -316 %, a 172% decline year-over-year.
  • Leap Therapeutics, Inc. annual Return On Equity for 2024 was -137 %, a 2.91% decline from 2023.
  • Leap Therapeutics, Inc. annual Return On Equity for 2023 was -133 %, a 89.5% decline from 2022.
  • Leap Therapeutics, Inc. annual Return On Equity for 2022 was -70.3 %, a 26.8% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

LEAP THERAPEUTICS, INC. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -316 -200 -172% Jul 1, 2025 Sep 30, 2025
Q2 2025 -238 -140 -142% Apr 1, 2025 Jun 30, 2025
Q1 2025 -162 -81.2 -100% Jan 1, 2025 Mar 31, 2025
Q4 2024 -137 -3.88 -2.91% Oct 1, 2024 Dec 31, 2024
Q3 2024 -116 +17 +12.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 -98 +38.7 +28.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -81 +62.1 +43.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -133 -62.9 -89.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -133 -74.1 -125% Jul 1, 2023 Sep 30, 2023
Q2 2023 -137 -88.1 -182% Apr 1, 2023 Jun 30, 2023
Q1 2023 -143 -95.7 -202% Jan 1, 2023 Mar 31, 2023
Q4 2022 -70.3 -14.9 -26.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -59.2 +3.79 +6.01% Jul 1, 2022 Sep 30, 2022
Q2 2022 -48.5 +28.7 +37.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -47.4 +12.1 +20.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -55.4 +6.59 +10.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -63 +26.2 +29.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -77.2 +68.5 +47% Apr 1, 2021 Jun 30, 2021
Q1 2021 -59.5 +326 +84.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -62 +352 +85% Oct 1, 2020 Dec 31, 2020
Q3 2020 -89.2 +130 +59.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 -146 +56.4 +27.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 -385 -198 -105% Jan 1, 2020 Mar 31, 2020
Q4 2019 -414 -204 -96.9% Oct 1, 2019 Dec 31, 2019
Q3 2019 -219 +52.1 +19.2% Jul 1, 2019 Sep 30, 2019
Q2 2019 -202 +44.4 +18% Apr 1, 2019 Jun 30, 2019
Q1 2019 -188 +28.7 +13.3% Jan 1, 2019 Mar 31, 2019
Q4 2018 -210 -27.7 -15.2% Oct 1, 2018 Dec 31, 2018
Q3 2018 -271 -522 -208% Jul 1, 2018 Sep 30, 2018
Q2 2018 -246 Apr 1, 2018 Jun 30, 2018
Q1 2018 -216 Jan 1, 2018 Mar 31, 2018
Q4 2017 -182 Oct 1, 2017 Dec 31, 2017
Q3 2017 250 Jul 1, 2017 Sep 30, 2017

LEAP THERAPEUTICS, INC. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -137 -3.88 -2.91% Jan 1, 2024 Dec 31, 2024
2023 -133 -62.9 -89.5% Jan 1, 2023 Dec 31, 2023
2022 -70.3 -14.9 -26.8% Jan 1, 2022 Dec 31, 2022
2021 -55.4 +6.59 +10.6% Jan 1, 2021 Dec 31, 2021
2020 -62 +352 +85% Jan 1, 2020 Dec 31, 2020
2019 -414 -204 -96.9% Jan 1, 2019 Dec 31, 2019
2018 -210 -27.7 -15.2% Jan 1, 2018 Dec 31, 2018
2017 -182 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.